NCT03654352View on ClinicalTrials.gov

The ASTERS Study: Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome (ARDS)

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

March 12, 2021

Study Completion Date

March 12, 2021

Conditions
Acute Lung InjuryAcute Respiratory Distress Syndrome
Trial Locations (1)

40536

University of Kentucky Chandler Medical Center, Lexington

All Listed Sponsors
lead

Sturgill

OTHER

NCT03654352 - The ASTERS Study: Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome (ARDS) | Biotech Hunter | Biotech Hunter